Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality

Vaccine. 2020 Jul 22;38(34):5398-5401. doi: 10.1016/j.vaccine.2020.06.047. Epub 2020 Jun 19.
No abstract available

Keywords: COVID-19; Influenza vaccines; PPV23 vaccine; Transmission.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aged
  • COVID-19
  • Coronavirus Infections / complications*
  • Coronavirus Infections / mortality*
  • Coronavirus Infections / prevention & control
  • Humans
  • Influenza Vaccines / administration & dosage
  • Influenza Vaccines / supply & distribution*
  • Pandemics / prevention & control
  • Pneumococcal Vaccines / administration & dosage
  • Pneumococcal Vaccines / supply & distribution*
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / mortality*
  • Pneumonia, Viral / prevention & control
  • Respiratory Tract Infections / complications*
  • Respiratory Tract Infections / mortality
  • Respiratory Tract Infections / prevention & control*
  • Risk Assessment
  • Seasons*
  • Vaccination
  • Vaccines, Conjugate / administration & dosage

Substances

  • Influenza Vaccines
  • Pneumococcal Vaccines
  • Vaccines, Conjugate